TDOC has 36-month beta value of 0.94. Analysts have mixed views on the stock, with 4 analysts rating it as a “buy,” 1 as “overweight,” 22 as “hold,” and 0 as “sell.”
The public float for TDOC is 165.21M, and currently, short sellers hold a 12.28% ratio of that float. The average trading volume of TDOC on April 01, 2024 was 4.65M shares.
TDOC) stock’s latest price update
Teladoc Health Inc (NYSE: TDOC)’s stock price has plunge by -3.58relation to previous closing price of 15.10. Nevertheless, the company has seen a -2.93% plunge in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-03-28 that Teladoc’s (TDOC) Integrated Care business is expected to gain from margin expansion and improving chronic care program enrollment.
TDOC’s Market Performance
Teladoc Health Inc (TDOC) has experienced a -2.93% fall in stock performance for the past week, with a -3.45% drop in the past month, and a -34.12% drop in the past quarter. The volatility ratio for the week is 2.11%, and the volatility levels for the past 30 days are at 3.16% for TDOC. The simple moving average for the last 20 days is -3.53% for TDOC stock, with a simple moving average of -28.30% for the last 200 days.
Analysts’ Opinion of TDOC
Many brokerage firms have already submitted their reports for TDOC stocks, with Cantor Fitzgerald repeating the rating for TDOC by listing it as a “Overweight.” The predicted price for TDOC in the upcoming period, according to Cantor Fitzgerald is $22 based on the research report published on February 29, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see TDOC reach a price target of $17. The rating they have provided for TDOC stocks is “Market Perform” according to the report published on February 26th, 2024.
DA Davidson gave a rating of “Neutral” to TDOC, setting the target price at $22 in the report published on January 17th of the current year.
TDOC Trading at -16.71% from the 50-Day Moving Average
After a stumble in the market that brought TDOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -52.12% of loss for the given period.
Volatility was left at 3.16%, however, over the last 30 days, the volatility rate increased by 2.11%, as shares sank -2.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -26.35% lower at present.
During the last 5 trading sessions, TDOC fell by -2.53%, which changed the moving average for the period of 200-days by -42.30% in comparison to the 20-day moving average, which settled at $15.07. In addition, Teladoc Health Inc saw -32.44% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TDOC starting from Geshuri Arnnon, who sale 7,500 shares at the price of $15.06 back on Mar 25 ’24. After this action, Geshuri Arnnon now owns 38,470 shares of Teladoc Health Inc, valued at $112,950 using the latest closing price.
Trencher Daniel, the CHIEF STRATEGY OFFICER of Teladoc Health Inc, sale 1,000 shares at $15.18 during a trade that took place back on Mar 18 ’24, which means that Trencher Daniel is holding 27,192 shares at $15,180 based on the most recent closing price.
Stock Fundamentals for TDOC
Current profitability levels for the company are sitting at:
- -0.1 for the present operating margin
- 0.71 for the gross margin
The net margin for Teladoc Health Inc stands at -0.08. The total capital return value is set at -0.06. Equity return is now at value -9.51, with -4.69 for asset returns.
Based on Teladoc Health Inc (TDOC), the company’s capital structure generated 0.41 points at debt to capital in total, while cash flow to debt ratio is standing at 0.22. The debt to equity ratio resting at 0.68. The interest coverage ratio of the stock is -11.15.
Currently, EBITDA for the company is 192.05 million with net debt to EBITDA at -2.9. When we switch over and look at the enterprise to sales, we see a ratio of 1.12. The receivables turnover for the company is 11.31for trailing twelve months and the total asset turnover is 0.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.46.
Conclusion
To put it simply, Teladoc Health Inc (TDOC) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
